A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...

Viral video of a dog-bite victim 'barking' sparks nationwide debate on rabies awareness, stray dog population control and gaps in healthcare access in India.

On March 10, 2026, the team led by Dr. An Chiying at Shenzhen Hengsheng Hospital, affiliated with Shanghai Fosun Health, publicly announced that through an innovative integrative medical approach, ...

Delivering treatments to someone under the age of 18 is to be outlawed under the legislation.

With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...

Scroll long enough and it stops feeling fringe. It starts feeling strategic.What once lived in niche bodybuilding forums has migrated to the 'For You' page. Now it's framed as "optimisation" — sharper ...

The powerful gene-editing technique CRISPR–Cas9 might offer a way to make safer, more effective cancer-fighting immune cells ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase ...

Instead, they relentlessly lumber around our bodies, damaging healthy cells and oozing inflammation. This accelerates ageing ...

Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE™ (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for the treatment of ...

So many options. So much noise. Here's what to know about GLP-1s now.